All-cause mortality before and after DAA availability among people living with HIV and HCV

An international comparison between 2010 and 2019

Dados Bibliográficos

ID14907129
AutoresMaria-Bernarda Requena (0000-0003-3787-8602, Inserm), Camelia Protopopescu (0000-0003-0164-7917, Inserm, autor correspondente), Ashleigh C Stewart (0000-0002-1399-3385, Burnet Institute), Daniela K van Santen (0000-0001-7625-3336, GGD Amsterdam), Marina B Klein (0000-0002-3063-8430, McGill University Health Centre), Inmaculada Jarrin (0000-0002-7485-2252, Instituto de Salud Carlos III), Juan Berenguer (0000-0001-8541-8200, Hospital General Universitario Gregorio Marañón), Linda Wittkop (0000-0003-2403-0960, Institut national de recherche en sciences et technologies du numérique), Dominique Salmon (0000-0003-1229-2429, Université Paris Cité), Andri Rauch (0000-0001-5297-6062, University of Bern), Maria Prins (0000-0003-2967-0289, GGD Amsterdam), Marc van der Valk (0000-0002-8290-6425, Stichting HIV Monitoring), Rachel Sacks-Davis (0000-0003-0860-2762, Burnet Institute), Margaret Hellard (0000-0002-5055-3266, Burnet Institute), Patrizia Carrieri (0000-0002-6794-4837, Inserm), Karine Lacombe (0000-0001-8772-9029, Inserm)
Ano2024
Volume124
Páginas104311
Data de publicação2024-02-01
Peer ReviewedSim
Open AccessSim
TipoARTICLE
PeriódicoInternational Journal of Drug Policy (JOURNAL)
Identificadores do periódicoISSN: 0955-3959 • E-ISSN: 1873-4758
EditoraElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2023.104311
PMID38184902
OpenAlexW4390644434
IdiomaEN
Referências citadas41